FK-041

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFK-041
Drug Alias NameFK-041
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionPenicillin-binding protein 3 inhibitorsCell wall inhibitors
TargetsPenicillin-binding protein 3
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A